Orchestra Share Price

Orchestra Share Price

NASDAQ: OBIO | Small Cap | Healthcare
$7.53
+$0.57 (8.11%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Orchestra Stock Performance

Open
$7.10
Prev. Close
$6.96
Circuit Range
N/A
Day Range
$7.10 - $7.82
Year Range
$3.47 - $7.82
Volume
41,178
Average Traded
$7.50

Orchestra Share Price Today

As of 19 November 2026, Orchestra BioMed Holdings, Inc.'s share price is $7.53. The stock opened at $7.10, compared to its previous close of $6.96. During today's trading session, Orchestra BioMed Holdings, Inc.'s share price traded between $7.10 and $7.82, with an average price of $7.46. Over the past 52 weeks, the stock has recorded a high of $7.82 and a low of $3.47. In terms of performance, Orchestra BioMed Holdings, Inc.'s share price has risen by 93.57% over the last six months and is up 41.54% on a year-on-year basis.

Orchestra Share Price Chart

Line chart of the Orchestra price trend over the selected period. The price rose overall, ranging from 7.07 to 7.82, ending at 7.53.
$7.10$7.82
L
Show Current Price
H

Orchestra Stock Fundamentals & Key Indicators

Market Cap
$359.54M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.74
Revenue (TTM)
$33.48B
Return On Equity (TTM)
-749.95%
Profit Margin
-158.18%
Debt to Equity
4.58
Quarterly Earnings Growth YoY
-427.55%

Orchestra Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$30.92$0.11$0.09$0.09
Net Profit$5.99-$20.66-$24.08-$19.62
Net Profit Margin19.37%-18781.82%-26755.56%-21800.00%
Income ChangeN/A-444.91%-16.55%18.52%

Orchestra Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2.76$2.64$33.48
Net Profit-$49.12-$61.02-$52.96
Net Profit Margin-1779.71%-2311.36%-158.18%
Income ChangeN/A-24.23%13.21%

Orchestra Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets6.957.06.1
Current Assets107.9169.1789.11
Total Assets114.8676.1795.21
Non Current Liabilities34.7427.0115.96
Current Liabilities16.7416.2111.21
Total Liabilities51.4843.2227.17
Shareholders' Equity53.5732.9668.04

Orchestra Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-48.96-50.56-46.13
Investing-26.9413.0910.69
Financing88.3329.1746.22

About Orchestra

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Orchestra Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.02
$7.51
+27.48%
Oct 2026
$6.25
$5.89
-5.30%
Sep 2026
$5.00
$6.22
+22.06%
Aug 2026
$4.08
$5.10
+28.63%
Jul 2026
$4.32
$3.96
-8.22%
Jun 2026
$3.90
$4.32
+11.05%
May 2026
$3.98
$3.89
-2.38%
Apr 2026
$4.43
$3.98
-6.57%
Mar 2026
$4.27
$4.26
-2.63%
Feb 2026
$3.71
$4.38
+25.14%
Jan 2026
$4.25
$3.50
-15.46%
Dec 2025
$5.29
$4.14
-22.18%

Orchestra Share Price FAQs